Mechanisms of dili potential idiosyncratic toxicities. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Liver Hepatocytes Cells, Cultured Cell Line, Tumor Kidney Cell Line Bone Marrow Neurons Lung Tumor Cells, Cultured

Organisms12

Rats, Sprague-Dawley Rats, Inbred F344 Daphnia Mice, Inbred C57BL Bacillus thuringiensis Rats, Wistar Mice, Inbred BALB C Artemia Larva Mice, Nude Rabbits Mice, Inbred ICR

Diseases47

Drug-Induced Liver Injury Drug-Related Side Effects and Adverse Reactions Liver Failure, Acute Necrosis HIV Infections Neoplasms Leukopenia Radiation Injuries Neutropenia Hematologic Diseases Lung Neoplasms Thrombocytopenia Nausea Neurotoxicity Syndromes Body Weight Neoplasm Metastasis Plant Poisoning Neoplasm Recurrence, Local Stomatitis Breast Neoplasms Adenocarcinoma Abnormalities, Drug-Induced Vomiting Carcinoma, Non-Small-Cell Lung Drug Eruptions Disease Models, Animal Gastrointestinal Diseases Drug Overdose Poisoning Mucositis Colorectal Neoplasms Disease Progression Exanthema Head and Neck Neoplasms Ovarian Neoplasms Prostatic Neoplasms Radiodermatitis Brain Neoplasms Male Urogenital Diseases Lymphoma, Non-Hodgkin Kidney Diseases Melanoma Alopecia Diarrhea Kidney Neoplasms Liver Neoplasms Carcinoma, Squamous Cell

Chemicals and Drugs94

Acetaminophen Alanine Transaminase Antitubercular Agents Antineoplastic Agents Biological Markers Cisplatin Fluorouracil Doxorubicin Deoxycytidine Antineoplastic Agents, Phytogenic Antimetabolites, Antineoplastic Paclitaxel Antidotes Camptothecin Cyclophosphamide Carboplatin Taxoids Teratogens Organoplatinum Compounds Water Pollutants, Chemical Leucovorin Etoposide Environmental Pollutants Glutathione Insecticides Vinblastine Methotrexate Antineoplastic Agents, Alkylating Plant Extracts Vincristine Antibiotics, Antineoplastic Antibodies, Monoclonal Prodrugs Ifosfamide Cadmium Methylmercury Compounds Dacarbazine Aluminum Cytochrome P-450 CYP2E1 Neurotoxins Dihydrouracil Dehydrogenase (NADP)Drug Carriers Bacterial Toxins Amyloid beta-Peptides Recombinant Proteins Antioxidants Antibodies, Monoclonal, Humanized Bleomycin Reactive Oxygen Species L-Lactate Dehydrogenase Topotecan Amifostine Melphalan Herbicides Immunotoxins Xenobiotics Endotoxins Cytarabine Tetrachlorodibenzodioxin Enzyme Inhibitors Liposomes Toxins, Biological Epirubicin Carmustine Drug Combinations Prednisone Organophosphorus Compounds Quinazolines Thiazoles Superoxide Dismutase Ethylene Glycols Paraquat Yttrium Radioisotopes Selenium Compounds Hazardous Substances Niacinamide Radiation-Sensitizing Agents Mitomycin Peptides Metals, Heavy Mercury Lead Neuroprotective Agents Polyethylene Glycols Carcinogens Mycotoxins Mitoxantrone Copper Phenylurea Compounds Pyridines Benzenesulfonates Amphotericin B Tegafur Guanine

Analytical, Diagnostic and Therapeutic Techniques and Equipment64

Toxicity Tests Toxicity Tests, Acute Liver Function Tests Lethal Dose 50 Risk Factors Antineoplastic Combined Chemotherapy Protocols Toxicity Tests, Chronic Drug Administration Schedule Prospective Studies Biopsy Treatment Outcome Severity of Illness Index Infusions, Intravenous No-Observed-Adverse-Effect Level Maximum Tolerated Dose Administration, Oral Combined Modality Therapy Incidence Drug Evaluation Toxicity Tests, Subchronic Survival Analysis Disease-Free Survival Radiotherapy Dosage Drug Evaluation, Preclinical Survival Rate Animal Testing Alternatives Radiotherapy Organ Size Toxicity Tests, Subacute Dose Fractionation Body Weight Radiotherapy, Conformal Area Under Curve Neoplasm Staging Remission Induction Injections, Intravenous Salvage Therapy Radioimmunotherapy Clinical Trials, Phase I as Topic Drug Carriers Radiotherapy, Intensity-Modulated Disease Models, Animal Follow-Up Studies Drug Delivery Systems Drug Overdose Feasibility Studies Chemotherapy, Adjuvant Mutagenicity Tests Retrospective Studies Hematologic Tests Injections, Intraperitoneal Clinical Trials as Topic Metabolic Clearance Rate Chemoradiotherapy Dose-Response Relationship, Radiation Drug Therapy, Combination Blood Cell Count Carcinogenicity Tests Models, Biological Biological Assay Injections, Subcutaneous Inhibitory Concentration 50 Pilot Projects Chromatography, High Pressure Liquid

Phenomena and Processes31

Necrosis Dose-Response Relationship, Drug Lethal Dose 50 No-Observed-Adverse-Effect Level Cell Survival Maximum Tolerated Dose Time Factors Drug Interactions Organ Size Body Weight Area Under Curve Oxidative Stress Apoptosis Tissue Distribution Drug Synergism Cell Death Biotransformation Metabolic Detoxication, Drug Particle Size Drug Resistance, Neoplasm Mutation Molecular Structure Structure-Activity Relationship Metabolic Clearance Rate Dose-Response Relationship, Radiation Blood Cell Count Half-Life Cytoprotection Larva Inhibitory Concentration 50 Genetic Vectors

Disciplines and Occupations3

Toxicology Toxicogenetics Ecotoxicology

Technology, Industry, Agriculture4

Nanoparticles Metal Nanoparticles Liposomes Polyethylene Glycols

Information Science5

Terminology as Topic Incidence Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated

Health Care19

Risk Factors Prospective Studies Treatment Outcome Severity of Illness Index Incidence Radiation Injuries Survival Analysis Disease-Free Survival Survival Rate Area Under Curve Clinical Trials, Phase I as Topic Follow-Up Studies Feasibility Studies Retrospective Studies Clinical Trials as Topic Dose-Response Relationship, Radiation Societies, Scientific Pilot Projects Inhalation Exposure

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care Geographicals

Drug-Induced Liver Injury East Timor Drug-Related Side Effects and Adverse Reactions Toxicity Tests Liver Toxicity Tests, Acute Acetaminophen Liver Failure, Acute Alanine Transaminase Liver Function Tests Necrosis Antitubercular Agents Terminology as Topic Dose-Response Relationship, Drug Hepatocytes Lethal Dose 50 Risk Factors Antineoplastic Combined Chemotherapy Protocols Toxicity Tests, Chronic Drug Administration Schedule Prospective Studies Antineoplastic Agents Biopsy Treatment Outcome Biological Markers HIV Infections Severity of Illness Index Cisplatin Infusions, Intravenous No-Observed-Adverse-Effect Level Fluorouracil Cell Survival Maximum Tolerated Dose Neoplasms Administration, Oral Doxorubicin Combined Modality Therapy Incidence Time Factors Toxicology Deoxycytidine Drug Evaluation Leukopenia Antineoplastic Agents, Phytogenic Antimetabolites, Antineoplastic Radiation Injuries Paclitaxel Neutropenia Toxicity Tests, Subchronic Antidotes Survival Analysis Camptothecin Cyclophosphamide Disease-Free Survival Radiotherapy Dosage Carboplatin Hematologic Diseases Lung Neoplasms Taxoids Teratogens Drug Evaluation, Preclinical Survival Rate Organoplatinum Compounds Water Pollutants, Chemical Leucovorin Thrombocytopenia Etoposide Animal Testing Alternatives Environmental Pollutants Glutathione Rats, Sprague-Dawley Insecticides Vinblastine Methotrexate Radiotherapy Antineoplastic Agents, Alkylating Drug Interactions Organ Size Cells, Cultured Nausea Toxicity Tests, Subacute Neurotoxicity Syndromes Plant Extracts Dose Fractionation Vincristine Body Weight Antibiotics, Antineoplastic Nanoparticles Radiotherapy, Conformal Antibodies, Monoclonal Area Under Curve Cell Line, Tumor Oxidative Stress Neoplasm Staging Kidney Neoplasm Metastasis Plant Poisoning Apoptosis Tissue Distribution Drug Synergism

No FAQ available that match "mechanisms of dili potential idiosyncratic toxicities"